Learn about published research as well as leading-edge basic and translational research initiatives from St. Jude laboratories.
Powerful cancer data portal gets an upgrade to identify the genetic culprit for inherited cancer and possibly other genetic diseases.
Two friends and research colleagues are looking at different stages of the immune response to pave the way for enhanced cancer treatments.
High science calls on Star Wars character as a potential ally against Alzheimer’s disease.
St. Jude is testing adult cancer drug prexasertib in children with recurrent or refractory medulloblastoma to inhibit checkpoint kinase chk1/2.
An agreement between one U.S. hospital and two Chinese hospitals in 1991 has completely changed global pediatric cancer care.
Effective leukemia treatment is one thing – making sure it’s optimized with minimal implications is another. Read research juggles both to help patients.
Read how the discovery of this gene could change immunotherapy cancer and viral infection treatments.
Stress granules form from heat shock to the cell then disappear, but when treated with an inhibitor to the protein ULK, the stress granules persist event after removal of the stress.
Read how the length of these proteins may be an indicator of ALS.
It used to be just about surviving–now, it’s about treating children with ALL to live long, healthy lives. Learn about ALL survivorship research from ASCO.